LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0016667
 32.60 27.76 1685 2235 0.7536 0.9126
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 36.01 27.76 1877 2662 0.7049 0.8965
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 36.01 27.76 1905 2662 0.7154 0.9008
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 37.71 27.76 1942 2877 0.6749 0.8859
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 39.41 27.76 2088 3105 0.6723 0.8867
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 1.95 27.76 620 225 2.7538 1.7971
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 3.66 27.76 663 283 2.3351 1.5753
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 5.36 27.76 3 320 0.0094 -0.4677
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 7.06 27.76 815 360 2.2639 1.4947
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 8.76 27.76 36 401 0.0897 0.0698
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 10.46 27.76 96 438 0.2189 0.3656
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 10.46 27.76 933 438 2.1270 1.4174
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 13.87 27.76 1056 604 1.7463 1.2672
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 15.58 27.76 963 685 1.4047 1.1524
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 17.28 27.76 1083 838 1.2913 1.1067
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 17.28 27.76 1193 838 1.4224 1.1486
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 20.68 27.76 1283 1119 1.1466 1.0520
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 20.68 27.76 1358 1119 1.2136 1.0739
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 22.39 27.76 1397 1305 1.0699 1.0245
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 24.09 27.76 1415 1461 0.9681 0.9887
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 27.49 27.76 1523 1723 0.8839 0.9590
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 29.19 27.76 1611 1863 0.8647 0.9527
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 42.81 27.76 2261 3596 0.6287 0.8720
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 42.81 27.76 2240 3596 0.6229 0.8695
MN20160318_Q01
C03